Chromadex Corp
NASDAQ:CDXC 2:05:46 PM EDT
Earnings Announcements
ChromaDex Reports First Quarter 2022 Financial Results
Published: 05/12/2022 21:10 GMT
Chromadex Corp (CDXC) - Oration Reports First Quarter 2022 Financial Results.
Qtrly Total Net Sales Were $17.3 Million, Up 18% From Prior Year Quarter.
Qtrly Loss per Share $0.11.
Expects 15% -20% Revenue Growth for 2022.
Q1 Earnings per Share View $-0.09, Revenue View $17.2 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Total Net Sales Were $17.3 Million, Up 18% From Prior Year Quarter.
Qtrly Loss per Share $0.11.
Expects 15% -20% Revenue Growth for 2022.
Q1 Earnings per Share View $-0.09, Revenue View $17.2 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $18.98 Million
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $21.13 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.08
Next Quarter Revenue Guidance is expected to be $21.13 Million
Next Quarter EPS Guidance is expected to be -$0.06
More details on our Analysts Page.